Yellow light therapy is gaining traction for calming redness and supporting skin repair. Dermatologists explain the benefits, ...
Longeveron Inc. (NASDAQ: LGVN) a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that ...
Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, has been awarded an Advanced Research Projects Agency for Health (ARPA-H) contract to develop advanced ...
Vasomune Therapeutics, Inc. ("Vasomune"), a clinical-stage biopharmaceutical company developing therapies that target vascular leak, today announced that Dr. Harold Kim, Chief Scientific Officer, will ...
Two-year PRISM results show 4D-150 gene therapy sustains wet AMD vision while cutting anti-VEGF injections up to 87%, with ...
The St. Anna Children’s Hospital will soon offer gene therapy for children and adolescents with severe forms of sickle cell ...
NEWPORT NEWS, Va. and LONDON, July 22, 2026 /PRNewswire/ -- ivWatch, the IV safety company, today announced that its ...
A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk ...
6d
Researchers investigate potential connections between menopausal hormone therapy and ocular health
Faculty members at the University of Colorado Anschutz School of Medicine are working together across academic departments to ...
OPTIC data showed a single injection of Ixo-vec gene therapy cut annualized anti-VEGF injections 87%, with sustained ...
Opportunities span cell therapy, transplant expansion, standardized collection, digital traceability, AI-enabled workflows, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results